Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: A single-institution experience

Clinical Nuclear Medicine

Volumn 37, Issue 3, 2012, Pages 223-228

  Ciappuccini, Renaud ^a   Morera, Julia ^b   Pascal, Pierre ^a   Rame, Jean Pierre ^a   Heutte, Natacha ^a,c   Aide, Nicolas ^a   Babin, Emmanuel ^b   Reznik, Yves ^b   Bardet, Stéphane ^a  

^a CENTRE FRANÇOIS BACLESSE   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c UNIVERSITÉ DE CAEN   (France)

Author keywords

Hyperparathyroidism; Sestamibi; SPECT CT; Surgery

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NECK; OUTCOME ASSESSMENT; PARATHYROID ADENOMA; PRIMARY HYPERPARATHYROIDISM; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX; THYROID SURGERY; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCIUM; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; NECK; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M SESTAMIBI; THORAX; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84857212096     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31823362e5     Document Type: Article

References (31)

1. Fraser WD. Hyperparathyroidism. Lancet. 2009;374:145-158.
2. Lowe H, McMahon DJ, Rubin MR, et al. Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype. J Clin Endocrinol Metab. 2007;92:3001-3005. (Pubitemid 47236362)
3. Silverberg SJ, Shane E, Jacobs TP, et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999;341:1249-1255. (Pubitemid 29489739)
4. Yu N, Donnan PT, Leese GP. A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf). 2011;75:169-176. doi: 10.1111/j. 1365-2265.2010.03958.x.
5. Bollerslev J, Jansson S, Mollerup CL, et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab. 2007; 92:1687-1692. (Pubitemid 46997172)
6. Rubin MR, Bilezikian JP, McMahon DJ, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008;93:3462-3470.
7. Grant CS, Thompson G, Farley D, et al. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472-478.
8. Patel CN, Salahudeen HM, Lansdown M, et al. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010; 65:278-287.
9. Ishibashi M, Nishida H, Hiromatsu Y, et al. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands. J Nucl Med. 1998;39:320-324. (Pubitemid 28114526)
10. O'Doherty MJ, Kettle AG, Wells P, et al. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33:313-318.
11. Taillefer R, Boucher Y, Potvin C, et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (doublephase study). J Nucl Med. 1992;33:1801-1807.
12. Hindie E, Melliere D, Simon D, et al. Primary hyperparathyroidism: is technetium 99m-Sestamibi/iodine-123 subtraction scanning the best procedure to locate enlarged glands before surgery? J Clin Endocrinol Metab. 1995;80:302-307.
13. Lorberboym M, Minski I, Macadziob S, et al. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma. J Nucl Med. 2003;44:904-908. (Pubitemid 39663401)
14. Billotey C, Sarfati E, Aurengo A, et al. Advantages of SPECT in technetium-99m-sestamibi parathyroid scintigraphy. J Nucl Med. 1996;37:1773-1778. (Pubitemid 26378360)
15. Harris L, Yoo J, Driedger A, et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck. 2008;30:509-517. (Pubitemid 351578756)
16. Lavely WC, Goetze S, Friedman KP, et al. Comparison of SPECT/CT, SPECT, and planar imaging with single-and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48:1084-1089. (Pubitemid 47052646)
17. Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTcsestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49:2012-2017.
18. Levine DS, Belzberg AS, Wiseman SM. Hybrid SPECT/CT imaging for primary hyperparathyroidism: case reports and pictorial review. Clin Nucl Med. 2009;34:779-784.
19. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Endocrine Organs. Lyon, France: IARC Press; 2004.
20. Udelsman R, Pasieka JL, Sturgeon C, et al. Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:366-372.
21. Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. Long-term results. World J Surg. 2009;33:2256-2265.
22. Siperstein A, Berber E, Barbosa GF, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg. 2008; 248:420-428.
23. Akram K, Parker JA, Donohoe K, et al. Role of single photon emission computed tomography/computed tomography in localization of ectopic parathyroid adenoma: a pictorial case series and review of the current literature. Clin Nucl Med. 2009;34:500-502.
24. Gayed IW, Kim EE, Broussard WF, et al. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46:248-252. (Pubitemid 43073431)
25. Erbil Y, Kapran Y, Issever H, et al. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg. 2008;195:34-39. (Pubitemid 350234822)
26. Shiau YC, Tsai SC, Wang JJ, et al. Detecting parathyroid adenoma using technetium-99m tetrofosmin: comparison with P-glycoprotein and multidrug resistance related protein expression-a preliminary report. Nucl Med Biol. 2002;29:339-344. (Pubitemid 34258556)
27. Hindie E, Ugur O, Fuster D, et al. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36:1201-1216.
28. Swanson TW, Chan SK, Jones SJ, et al. Determinants of Tc-99m sestamibi SPECT scan sensitivity in primary hyperparathyroidism. Am J Surg. 2010; 199:614-620.
29. Marx SJ, Stock JL, Attie MF, et al. Familial hypocalciuric hypercalcemia: recognition among patients referred after unsuccessful parathyroid exploration. Ann Intern Med. 1980;92:351-356. (Pubitemid 10117621)
30. Kuchuk NO, Pluijm SM, van Schoor NM, et al. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab. 2009;94:1244-1250.
31. Pata G, Casella C, Besuzio S, et al. Clinical appraisal of 99m technetiumsestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter. Thyroid. 2010; 20:1121-1127.